AzTrials
AzTrials

Chronic Periodontitis (Disorder)NCT03041480

Serum Lipid Levels and Lp-PLA2 in Chronic Periodontitis

An observational study of Chronic Periodontitis (Disorder), run by Meenakshi Ammal Dental College and Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To assess the association between periodontal parameters, serum lipid profile and Lp-PLA2 level in systemically healthy Chronic Periodontitis subjects and healthy controls. Read more about this study

Who is it for?
Ages 35 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Chronic Periodontitis (Disorder)
What is being tested?
serum lipid levels and Lp-PLA2
How many people
75 participants
Where
No sites listed yet
Study dates
2 Feb 2015to 26 Nov 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The study population was selected from the Department of Periodontology, Meenakshi Ammal Dental College

Who may be able to join

  • Group I:
  • Subjects with age ≥ 35 years.
  • Presence of at least 24 teeth, with Clinical attachment loss (CAL) ≥ 5mm in more than 30% of sites.
  • Group II:
  • Subjects with age ≥ 35 years.
  • Presence of at least 24 teeth, with Clinical attachment loss (CAL) between 3-4 mm in more than 30% of sites.
Show all 9Show fewer
  • Group III:
  • Subjects with age ≥ 35 years.
  • Healthy and intact periodontium

Who cannot join

  • Presence of any systemic disease or conditions that could affect periodontal tissues.
  • History of periodontal treatment in past 6 months.
  • Smoking and alcoholism
  • Anomalies of blood and immune system
  • Systemic medication or antibiotic treatment for the previous 6 months.
  • Pregnant females.

About this study

Official title: The Association Between Periodontal Status, Serum Lipid Levels and Lipoprotein Associated Lipophosphase A2(Lp-PLA2) in Chronic Periodontitis Subjects and Healthy Controls: A Case Control Study

To assess the association between periodontal parameters, serum lipid profile and Lp-PLA2 level in systemically healthy Chronic Periodontitis subjects and healthy controls.

Read the detailed description

Seventy five participants were divided into 3 groups. The groups consisted of GROUP I- generalized severe chronic periodontitis, GROUP II- generalized moderate chronic periodontitis and GROUP III- systemically and periodontally healthy volunteers who served as control. The selected patients were then evaluated for periodontal parameters, lipid profile and Lp-PLA2.

Being tested
serum lipid levels and Lp-PLA2
Keywords
chronic periodontitis, lipids, Lp-PLA2
Medical subject headings
Chronic Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • serum lipid levels and Lp-PLA2Diagnostic test

    Also called Biological marker

    Estimation of Total Cholesterol, triglyceride, High density lipoprotein, Low density lipoprotein, very low density lipoprotein and Lipoprotein associated lipophosphase A2 in chronic periodontitis

Study groups in NCT03041480
Study groupRoleWhat they receive
GROUP IEstimation of serum lipid levels and Lp-PLA2 in generalized severe chronic periodontitis
Receives: Diagnostic Test: serum lipid levels and Lp-PLA2
GROUP IIEstimation of serum lipid levels and Lp-PLA2 in generalized moderate chronic periodontitis
Receives: Diagnostic Test: serum lipid levels and Lp-PLA2
GROUP IIIEstimation of serum lipid levels and Lp-PLA2 in systemically and periodontally healthy controls
Receives: Diagnostic Test: serum lipid levels and Lp-PLA2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Estimation of serum Lp-PLA2

    Serum Lp-PLA2 was estimated in all the groups using ELISA

    Measured: 9 months

Secondary outcomes (1)
  1. Estimation of serum lipid profile

    Serum Total cholesterol, triglyceride, High density lipoprotein, Low density lipoprotein and very low density lipoprotein

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Feb 2017 (estimated)
  2. Study start2 Feb 2015
  3. Primary completion23 Aug 2015
  4. Study completion26 Nov 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Other
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03041480
Sponsor's protocol ID
MADC/IRB/2015/91
Status last verified
Jan 2017
First submitted
1 Feb 2017
Last updated
2 Feb 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Zhou SY, Xiao WM, Ouyang XY. Lipoprotein-associated phospholipase A2 and serum lipid levels in subjects with chronic periodontitis and hyperlipidemia. Chin J Dent Res. 2012;15(1):25-9.

    PubMed 22866279
  • Fentoglu O, Koroglu BK, Kara Y, Dogan B, Yilmaz G, Sutcu R, Ay ZY, Tonguc MO, Orhan H, Tamer MN, Kirzioglu FY. Serum lipoprotein-associated phospholipase A(2) and C-reactive protein levels in association with periodontal disease and hyperlipidemia. J Periodontol. 2011 Mar;82(3):350-9. doi: 10.1902/jop.2010.100417. Epub 2010 Sep 1.

    PubMed 20809860

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Periodontitis (Disorder), run by Meenakshi Ammal Dental College and Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Estimation of serum Lp-PLA2 (time frame: 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03041480, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in